Contract 75D30121P12571
Swift Biosciences, Inc. · Department Of Health And Human Services · September 20, 2021
Swift Biosciences, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 20, 2021 for $503,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Ann Arbor, MI. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 30, 2024.
Contract details
- PIID
- 75D30121P12571
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Ann Arbor, MI
- First action
- September 20, 2021
- Latest action
- March 30, 2024
Description
REAGENTS FOR SARS-COV-2 VARIANT SURVEILLANCE
Modification timeline
-
March 30, 2024Mod P00004$-339
-
December 8, 2021Mod P00003$167.9K
-
December 3, 2021Mod P00002$0
-
November 22, 2021Mod P00001$167.9K
-
September 20, 2021Base award$167.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30121P12571?
Contract 75D30121P12571 is a federal contract awarded to Swift Biosciences, Inc. by Department Of Health And Human Services on September 20, 2021 for $503,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 75D30121P12571?
Swift Biosciences, Inc. won contract 75D30121P12571 from Department Of Health And Human Services.
How much is contract 75D30121P12571 worth?
Contract 75D30121P12571 has obligated $503,000 to date, with a total potential value of $504,000 if all options are exercised.